James Enlou Tcheng

Professor of Medicine

Medicine, Cardiology

tchen001@mc.duke.edu

Duke Box 2708, Durham, NC 27710

Suite 403 Hock Plaza, 2424 Erwin Road, Durham, NC

Office hours Normal business hours.

More About This Person

At a Glance

Credentials
1. Education
2. Licensure

Academic Experience

Global Scholarship

Keywords

Research

Scholarly Works

Teaching & Mentoring
1. Teaching Summary
2. Advising & Mentoring Summary

Recognition
1. Academic Honors

Professional Activities
1. Service to the Profession
2. Leadership & Clinical Positions

Embed Profile Data

Embed Profile Data

Scholarly Works - Conferences

TWO YEAR EXPERIENCE WITH HIGH-SENSITIVITY TROPONIN TESTING:INTERPRETATIVE VALUES FOR IMPROVING PATIENT DISPOSITION

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 8, 2022 Link to item Cite

Abstract 14529: Management of Acute Myocardial Infarction in a Patient With a Left Ventricular Assist Device

Conference Circulation · November 17, 2020 Introduction: We present a case of an LVAD patient presenting with nonspecific symptoms found to have type I MI due to critical LAD stenosis. Full text Cite

Development and Initial Utilization of a Multi-institutional Distributed Data Network Designed to Evaluate Real-world Clinical Outcomes in Patients Presenting for Percutaneous Coronary Intervention (PCI): Results From the Building the Unique Device Identifier (UDI) Into Longitudinal Data for Medical Device Evaluation (BUILD) Network

Conference CIRCULATION · November 17, 2020 Link to item Cite

Coronary artery bypass grafting versus percutaneous coronary intervention for left main disease in chronic kidney disease patients: a meta-analysis

Conference EUROPEAN HEART JOURNAL · November 2020 Link to item Cite

TCT CONNECT-187 Characteristics Associated With Reduced Patient Radiation Dose in an Academic Cardiac Catheterization Lab

Conference Journal of the American College of Cardiology · October 2020 Full text Cite

Reducing Disparities in Coronary Interventional Outcomes in a Diverse, High Risk Population

Conference CIRCULATION · November 6, 2018 Link to item Cite

Antiplatelet Therapy Only (Without Anticoagulation) in Higher Risk Coronary Intervention With Very Short Infusion Glycoprotein Inhibitor

Conference CIRCULATION · November 6, 2018 Link to item Cite

CURRENT LANDSCAPE OF HYBRID REVASCULARIZATIONS: A REPORT FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY

Conference Journal of the American College of Cardiology · March 2018 Full text Cite

Optimizing Patient Care through Clinical Decision Support: Identification of Opportunities and Call to Action by the National Academy of Medicine.

Conference AMIA · 2017 Cite

TRENDS IN UPTAKE AND IN-HOSPITAL OUTCOMES WITH 2ND GENERATION DRUG ELUTING STENTS BETWEEN MEN AND WOMEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM THE CATHPCI REGISTRY

Conference Journal of the American College of Cardiology · April 2014 Full text Cite

DAMAGE TO POLYMER SURFACE AND DETACHMENT OF POLYMER FRAGMENTS DURING DELIVERY BALLOON EXPANSION OF DRUG-ELUTING STENTS: A PREVIOUSLY UNRECOGNIZED SOURCE FOR ADVERSE OUTCOMES

Conference Journal of the American College of Cardiology · March 2012 Full text Cite

Is Balloon Angioplasty without Stent Placement Adequate far Patients In Whom Early Coronary Artery Bypass Surgery Is Planned after Primary Percutaneous Coronary Intervention?

Conference CIRCULATION · October 28, 2008 Link to item Cite

Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods

Conference AMERICAN JOURNAL OF CARDIOLOGY · October 20, 2007 Link to item Cite

Impact of thienopyridine administration prior to primary stealing in acute myocardial infarction

Conference AMERICAN JOURNAL OF CARDIOLOGY · October 20, 2007 Link to item Cite

Relationship between leucocyte count, myonecrosis, myocardial perfusion and outcomes following primary angioplasty

Conference CIRCULATION · October 31, 2006 Link to item Cite

Local platelet glycoprotein IIb/IIIa receptor occupancy with intracoronary eptitibatide during stenting, the ICE pilot trial

Conference AMERICAN JOURNAL OF CARDIOLOGY · October 22, 2006 Link to item Cite

Low dose enoxaparin in non-ST segment elevation acute coronary syndrome, followed by antiplatelet therapy alone during subsequent percutaneous coronary intervention

Conference EUROPEAN HEART JOURNAL · August 1, 2006 Link to item Cite

A contemporary risk score for the prediction of long-term mortality following percutaneous coronary intervention with stent implantation: The duke PCI risk score

Conference CIRCULATION · October 25, 2005 Link to item Cite

Impact of eptifibatide therapy on outcome in patients undergoing multiple stent insertion: An ESPRIT subanalysis

Conference CIRCULATION · October 25, 2005 Link to item Cite

Higher baseline platelet count predicts reinfarction and death in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial

Conference CIRCULATION · October 25, 2005 Link to item Cite

Impact of baseline platelet count on outcomes of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial

Conference AMERICAN JOURNAL OF CARDIOLOGY · October 17, 2005 Link to item Cite

Impact of diabetes mellitus on myocardial perfusion following primary angioplasty in patients with acute myocardial infarction

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2005 Link to item Cite

Prediction of mortality following primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2005 Link to item Cite

Stroke after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2005 Link to item Cite

Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction. Results from the CADILLAC trial.

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2005 Link to item Cite

Adjunctive abciximab to reperfusion therapy in patients with acute st-segment elevation myocardial infarction: A meta-analysis of randomized trials

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2005 Link to item Cite

Integration of ST-segment recovery and myocardial blush for prediction of survival after primary percutaneous coronary intervention in acute myocardial infarction

Conference CIRCULATION · October 26, 2004 Link to item Cite

Adverse impact of multivessel disease on ST-segment recovery and clinical outcome in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction

Conference CIRCULATION · October 26, 2004 Link to item Cite

Prediction of survival after primary percutaneous coronary intervention by integration of ST-segment recovery and myocardial blush.

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 30, 2004 Link to item Cite

Reperfusion success and prognosis in patients with anterior compared with nonanterior infarction: Insights from the CADILLAC trial.

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 30, 2004 Link to item Cite

Adverse impact of multivessel disease on ST-segment recovery and clinical outcome in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 30, 2004 Link to item Cite

Outcomes of percutaneous coronary intervention in patients with acute myocardial infarction excluded from randomization: The CADILLAC Trial.

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 30, 2004 Link to item Cite

Implications of stroke after primary angioplasty in acute myocardial infarction.

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 30, 2004 Link to item Cite

Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 3, 2004 Link to item Cite

869-2 Impact of intravenous beta-blockade during primary percutaneous intervention on convalescent left ventricular function

Conference Journal of the American College of Cardiology · March 2004 Full text Cite

1061-100 Predictors of reinfarction after ST elevation myocardial infarction and glycoprotein receptor blockade: Analysis from the CADILLAC trial

Conference Journal of the American College of Cardiology · March 2004 Full text Cite

801-3 Anemia worsens prognosis after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial

Conference Journal of the American College of Cardiology · March 2004 Full text Cite

1002-82 Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction: The obesity paradox

Conference Journal of the American College of Cardiology · March 2004 Full text Cite

Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: An analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial

Conference CIRCULATION · October 28, 2003 Link to item Cite

Administration of a loading dose amplifies the beneficial effect of thienopyridine pretreatment and complements the use of GP IIb/IIIa inhibitor therapy in patients undergoing percutaneous coronary intervention with stenting

Conference CIRCULATION · October 28, 2003 Link to item Cite

A randomized study of 1276 patients undergoing PCI using iodixanol (Visipaque) vs iopamidol (Isovue); Comparison of in-hospital and 30 day major adverse cardiac events. The results of the VICC trial

Conference CIRCULATION · October 28, 2003 Link to item Cite

Predictors of left ventricular ejection fraction following primary percutaneous intervention for acute myocardial infarction

Conference CIRCULATION · October 28, 2003 Link to item Cite

Marked survival benefit of peri-procedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty not previously treated with beta-blockers

Conference CIRCULATION · October 28, 2003 Link to item Cite

Closure devices and vascular complications among PCI patients receiving enoxaparin, GP Ilb/Illa inhibitors and clopidogrel: Insight from ELECT

Conference CIRCULATION · October 28, 2003 Link to item Cite

Is ST segment resolution predictive of mortality after primary PCI in both anterior and non-anterior infarction? Analysis from the CADILLAC trial

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Activated clotting time values measured with the actalyke machine are consistently lower than measurements obtained with the Hemochron-801

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Anemia worsens prognosis after primary Angioplasty in acute myocardial infarction: Analysis from the cadillac study

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Incidence and implications of in-hospital acquired thromhocytopenia in patients undergoing primary angioplasty for acute myocardial infarction

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Impact of myocardial blush analysis methodologies in predicting short and long-term mortality after primary angioplasty. The CADILLAC trial

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Does stenting and glycoprotein IIb/IIIa receptor blockade improve ST segment recovery and outcome in patients undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Impact of age on the outcomes of women with acute myocardial infarction undergoing primary coronary stenting

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Reduction of ischemic injury following coronary intervention: Results of the MC-1 to eliminate necrosis and damage trial (MEND-1)

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 15, 2003 Link to item Cite

Does ventricular geometry simply measure ejection fraction? An analysis from the occluded artery trial (OAT)

Conference HEART · May 1, 2003 Link to item Cite

Improved clinical outcomes with abciximab therapy in acute myocardial infarction: A systematic overview of randomized clinical trials

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Benefits and risks of abciximab use in primary Angioplasty for acute myocardial infarction: The CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Predictors of treatment delay in patients with acute myocardial infarction undergoing primary angioplasty: An analysis from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Predictors and sequelae of subacute thrombosis after percutaneous intervention in acute myocardial infarction: The CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Magnitude and impact of after hours treatment delay in patients undergoing primary Angioplasty for acute myocardial infarction: The CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Abciximab readministration: Final results of the Reopro(fi) read ministration registry

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

How important is time to treatment with primary percutaneous coronary intervention for acute myocardial infarction? Results from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Outcomes in patients requiring bail-out abciximab during primary intervention in acute myocardial infarction: Analysis from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Baseline features and clinical results in patients excluded from randomization from a large international trial of reperfusion strategies in acute myocardial infarction: The CADILLAC registry

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Marked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

ST-segment elevation resolution as a predictor of mortality in patients with thrombolysis in myocardial infarction III flow in the infarct artery after primary angioplasty: The CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Relationship between time to treatment, electrocardiographic ST-segment resolution, and outcomes with primary percutaneous coronary intervention for acute myocardial infarction: Results from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

Prognostic value of the absolute degree of ST-segment elevation of the ECG at baseline and after primary angioplasty: Analysis from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions

Conference European Heart Journal · March 2003 Full text Cite

P2870 Elective percutaneous coronary intervention using anti-platelet therapy alone, without unfractionated heparin or other anti-thrombin therapy

Conference European Heart Journal · March 2003 Full text Cite

Adjunctive pharmacotherapy confined to an anti-platelet regimen during elective percutaneous coronary intervention

Conference CIRCULATION · November 5, 2002 Link to item Cite

Exposing the gender gap in outcomes after primary intervention for acute myocardial infarction: Results from the CADILLAC trial

Conference CIRCULATION · November 5, 2002 Link to item Cite

Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trial

Conference CIRCULATION · November 5, 2002 Link to item Cite

Impact of smoking status in patients with acute myocardial infarction treated with primary percutaneous intervention: The smoker's paradox revisited

Conference CIRCULATION · November 5, 2002 Link to item Cite

Do acute myocardial intervention patients without ST-segment elevation have better outcomes after primary percutaneous coronary intervention? An analysis from the CADILLAC trial.

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 24, 2002 Link to item Cite

Impact of small vessel size on long-term outcomes after primary angioplasty and stenting in acute myocardial infarction: Results from the CADILLAC trial.

Conference AMERICAN JOURNAL OF CARDIOLOGY · September 24, 2002 Link to item Cite

Does optimal or stent-like PTCA provide equivalent outcomes compared to primary stenting in acute myocardial infarction? Early and late results from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 6, 2002 Link to item Cite

Does abciximab and stenting improve outcomes in elderly patients undergoing primary PCI for acute myocardial infarction: Data from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 6, 2002 Link to item Cite

Point-of-care measurement of platelet function before angioplasty strongly predicts early MACE and late TVR

Conference EUROPEAN HEART JOURNAL · 2002 Link to item Cite

Cost-effectiveness of abciximab and stenting in acute myocardial infarction: Results from the CADILLAC trial

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 2001 Link to item Cite

Minimal dose heparin with abciximab in coronary intervention: Efficacy and safety of a novel heparin dosing strategy

Conference ADVANCES IN CORONARY ARTERY DISEASE · 2001 Link to item Cite

A prospective multicenter study to determine the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention - The GOLD study

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 2000 Link to item Cite

High-dose eptifibatide (Integrilin®) in elective coronary stent implantation:: results of the ESPRIT trial

Conference EUROPEAN HEART JOURNAL · 2000 Link to item Cite

Future trends in PTCA: Online transmission of angiographic data.

Conference AMERICAN JOURNAL OF CARDIOLOGY · October 1998 Link to item Cite

GP IIb/IIIa blockade during coronary intervention for unstable angina: Longer is not better.

Conference AMERICAN JOURNAL OF CARDIOLOGY · October 1998 Link to item Cite

Clinical outcome is improved at 30 days regardless of pre-treatment clinical and angiographic risk in patients receiving abciximab for angioplasty: Results from the EPILOG study

Conference CIRCULATION · October 15, 1996 Link to item Cite

Efficacy of abciximab, despite patient weight, using lower heparin dosing during percutaneous coronary interventions

Conference CIRCULATION · October 15, 1996 Link to item Cite